Showing results (491-500 of 583) with videos related to
Sort By:
Pageof 59
International Journal of Radiation Oncology, Biology, Physics|December 1, 1996
Preferential radiosensitization of G1 checkpoint-deficient cells by methylxanthinesK J Russell, L W Wiens, G W Demers, et al.Blood|April 1, 1993
Long-term follow-up of a phase III study of recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid malignanciesS N Rabinowe, D Neuberg, P J Bierman, et al.Bone Marrow Transplantation|June 1, 1995
Phase III randomized, double-blind placebo-controlled trial of rhGM-CSF following allogeneic bone marrow transplantationJ Nemunaitis, C S Rosenfeld, R Ash, et al.Bone Marrow Transplantation|January 1, 1991
Long-term follow-up of patients who received recombinant human granulocyte-macrophage colony stimulating factor after autologous bone marrow transplantation for lymphoid malignancyJ Nemunaitis, J W Singer, C D Buckner, et al.Blood|April 1, 1992
Differences in the frequency of normal and clonal precursors of colony-forming cells in chronic myelogenous leukemia and acute myelogenous leukemiaI D Bernstein, J W Singer, F O Smith, et al.Cancer|June 18, 2011
Pixantrone dimaleate in combination with fludarabine, dexamethasone, and rituximab in patients with relapsed or refractory indolent non-Hodgkin lymphoma: phase 1 study with a dose-expansion cohortTomasz P Srokowski, James E Liebmann, Manuel R Modiano, et al.The New England Journal of Medicine|June 20, 1991
Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancerJ Nemunaitis, S N Rabinowe, J W Singer, et al.The New England Journal of Medicine|August 20, 1987
Clonal development, stem-cell differentiation, and clinical remissions in acute nonlymphocytic leukemiaP J Fialkow, J W Singer, W H Raskind, et al.British Journal of Haematology|December 28, 2019
Pixantrone plus rituximab versus gemcitabine plus rituximab in patients with relapsed aggressive B-cell non-Hodgkin lymphoma not eligible for stem cell transplantation: a phase 3, randomized, multicentre trial (PIX306)Ruth Pettengell, Monika Długosz-Danecka, David Andorsky, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 24, 2016
Colony-Stimulating Factor-1 Receptor Is Required for Nurse-like Cell Survival in Chronic Lymphocytic LeukemiaAvery Polk, Ye Lu, Tianjiao Wang, et al.Pageof 59